|
|
Name: |
Frazier Life Sciences Management L.P. |
City: |
Menlo Park |
State: |
CA |
Zip: |
94025 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
14 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
MIRM |
Mirum Pharmaceuticals, Inc. |
1 |
- |
$0.00 |
$191,744,000 |
6,495,392 |
10.25% |
-12,720,000 |
25,000 |
17.617 |
N/A |
|
ALPN |
Alpine Immune Sciences Inc |
10 |
- |
$64.95 |
$59,677,000 |
3,131,008 |
3.19% |
25,490,000 |
145,251 |
6.82 |
N/A |
|
APLS |
Apellis Pharmaceuticals Inc |
11 |
- |
$41.20 |
$52,986,000 |
885,165 |
2.83% |
29,628,000 |
271,122 |
0.773 |
N/A |
|
RCKT |
Rocket Pharmaceuticals |
12 |
- |
$23.38 |
$45,645,000 |
1,523,013 |
2.44% |
16,897,000 |
120,000 |
1.934 |
N/A |
|
IRON |
Disc Medicine, Inc |
13 |
- |
$31.84 |
$45,342,000 |
785,000 |
2.42% |
14,570,000 |
130,000 |
4.509 |
N/A |
|
KALV |
Kalvista Pharmaceuticals Inc |
14 |
- |
$12.49 |
$44,373,000 |
3,622,294 |
2.37% |
13,183,000 |
383,435 |
10.729 |
N/A |
|
EWTX |
Edgewise Therapeutics, Inc. |
16 |
- |
$0.00 |
$29,179,000 |
2,667,203 |
1.56% |
24,314,000 |
1,818,181 |
3.821 |
N/A |
|
ARQT |
Arcutis Biotherapeutics, Inc. |
19 |
- |
$8.13 |
$28,308,000 |
8,764,232 |
1.51% |
-17,805,000 |
80,000 |
11.669 |
N/A |
|
MGNX |
Macrogenics Inc |
22 |
- |
$4.45 |
$23,104,000 |
2,401,704 |
1.24% |
14,701,000 |
598,500 |
3.908 |
Biotechnology |
|
ACAD |
Acadia Pharmaceuticals Inc |
23 |
- |
$14.86 |
$22,885,000 |
730,917 |
1.22% |
9,737,000 |
100,020 |
0.455 |
Biotechnology |
|
DCPH |
Deciphera Pharmaceuticals, ... |
31 |
- |
$25.44 |
$16,482,000 |
1,021,800 |
0.88% |
11,776,000 |
651,800 |
1.677 |
N/A |
|
COGT |
Cogent Biosciences, Inc. |
39 |
- |
$7.35 |
$11,732,000 |
1,995,267 |
0.63% |
-2,906,000 |
493,884 |
2.523 |
N/A |
|
AGIO |
Agios Pharmaceuticals Inc |
40 |
- |
$34.14 |
$11,651,000 |
523,166 |
0.62% |
4,424,000 |
231,164 |
0.757 |
N/A |
|
TRVI |
Trevi Therapeutics, Inc. |
42 |
- |
$0.00 |
$9,891,000 |
7,381,090 |
0.53% |
-5,110,000 |
500,000 |
12.318 |
N/A |
|